drugset / Trial / NCT04839549

Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea

NCT04839549 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine patient preference and treatment outcomes with an intracanalicular dexamethasone (0.4mg) insert compared to a standard steroid drop regimen in the contralateral eye for the treatment of ocular rosacea.

Timeline

Start
2020-06-06
Primary completion
2022-11-29
Completion
2022-11-29

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of patient enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other
Comparator Fluoromethalone Unknown 0.1 % —